Anne Tybjærg-Hansen

Medicine & Life Sciences

1. Adrenergic Receptors 16%
2. Alleles 31%
3. Apolipoproteins B 21%
4. Apolipoproteins E 22%
5. Arrhythmogenic Right Ventricular Dysplasia 16%
6. ATP-Binding Cassette Transporters 16%
7. Blood Pressure 16%
8. Body Mass Index 26%
9. C-Reactive Protein 33%
10. Cardiovascular Diseases 43%
11. Case-Control Studies 15%
12. Cerebrovascular Disorders 24%
13. Cholesterol 34%
14. Chronic Obstructive Pulmonary Disease 40%
15. Cohort Studies 17%
16. Confidence Intervals 38%
17. Coronary Disease 28%
18. Gallstones 22%
19. Genes 29%
20. Genetic Variation 35%
21. Genome-Wide Association Study 20%
22. Genotype 58%
23. HDL Cholesterol 39%
24. HDL Lipoproteins 23%
25. Heart 41%
26. Heterozygote 49%
27. Homozygote 23%
28. Hyperlipoproteinemia Type II 19%
29. LDL Cholesterol 48%
30. Lipids 18%
31. Lipoprotein(a) 46%
32. Lipoproteins 22%
33. Lung 19%
34. Mendelian Randomization Analysis 17%
35. Meta-Analysis 48%
36. Mortality 18%
37. Mutation 38%
38. Myocardial Infarction 50%
39. Myocardial Ischemia 100%
40. Odds Ratio 31%
41. Population 82%
42. Prospective Studies 21%
43. Random Allocation 59%
44. Single Nucleotide Polymorphism 22%
45. Stroke 24%
46. Transferrin 19%
47. Triglycerides 38%
48. Type 2 Diabetes Mellitus 21%
49. Vascular Diseases 31%
50. Venous Thromboembolism 16%